Maayan Hannah, Cohen-Poradosu Ronit, Halperin Efraim, Rudensky Bernard, Schlesinger Yechiel, Yinnon Amos M, Raveh David
Shaare Zedek Medical Centre, Jerusalem.
Scand J Infect Dis. 2004;36(11-12):878-81. doi: 10.1080/00365540410024925.
Moraxella is an aerobic, oxidase-positive, Gram-negative coccobacillus, which is rarely associated with serious and invasive infections. We describe 4 cases of Moraxella lacunata endocarditis and review 12 previously published cases of Moraxella endocarditis, including 1 further case with M. lacunata, 5 with M. catarrhalis, 2 with M. phenylperuvica and the remainder consisting of 1 case each of M. liquefaciens, M. osloensis, M. nonliquefaciens and 1 non-specified. Of these 16 patients, 5 had prosthetic valves, 5 suffered from an underlying heart abnormality, and the other 6 had normal hearts. Therapy consisted of a beta-lactam antimicrobial and, in several instances, an aminoglycoside as well. The mean duration of antibiotic treatment was 35+/-13 d. Four patients (25%) underwent surgery and 4 out of 16 (25%) died. Moraxella should be added to the growing list of organisms which may occasionally cause infective endocarditis, even in patients without preexisting valvular abnormality.
莫拉克斯氏菌属是一种需氧、氧化酶阳性、革兰氏阴性球杆菌,很少引起严重和侵袭性感染。我们描述了4例腔隙莫拉克斯氏菌心内膜炎病例,并回顾了之前发表的12例莫拉克斯氏菌心内膜炎病例,其中包括另外1例腔隙莫拉克斯氏菌病例、5例卡他莫拉菌病例、2例苯丙莫拉克斯氏菌病例,其余病例分别为液化莫拉克斯氏菌、奥斯陆莫拉克斯氏菌、非液化莫拉克斯氏菌各1例以及1例未明确的病例。在这16例患者中,5例有人工瓣膜,5例有潜在心脏异常,另外6例心脏正常。治疗包括使用β-内酰胺类抗菌药物,在一些情况下还使用了氨基糖苷类药物。抗生素治疗的平均持续时间为35±13天。4例患者(25%)接受了手术,16例中有4例(25%)死亡。莫拉克斯氏菌应被添加到可能偶尔引起感染性心内膜炎的微生物名单中,即使是在没有预先存在瓣膜异常的患者中。